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Several herpesviruses, including cytomegalovirus, induce receptors for the Fc domain of murine immuno-
globulin G (IgG) molecules. Viral genes coding for these receptors have been characterized only for
alphaherpesviruses. In this report, we describe a new approach that led to the identification of an Fc receptor
(FcR) of murine cytomegalovirus (MCMV). The Fc fragment of IgG precipitated glycoproteins (gp) of 86 to 88
and 105 kDa from MCMV-infected cells. Deglycosylation by endoglycosidase F resulted in a protein with a
molecular mass of 64 kDa. Injection of complete MCMV DNA or ofDNA fragments, and the subsequent testing
of cytoplasmic binding of IgG by immunofluorescence microscopy, was used to search for the coding region in
the MCMV genome. The gene was located in the HindIII J fragment, map units 0.838 to 0.846, where an open
reading frame of 1,707 nucleotides predicts a gp of 569 amino acids with a calculated molecular mass of 65 kDa.
The sequence of this gp is related to those of the gE proteins of herpes simplex virus type 1 and varicella-zoster
virus. The defined length of the mRNA, 1,838 nucleotides, was in agreement with that of a 1.9-kb RNA
expressed throughout the replication cycle, starting at the early stages of infection. Expression of the genefcrl
by recombinant vaccinia virus resulted in the synthesis of gp86/88 and gplO5, each with FcR properties, and
the correct identification of the gene encoding the FcR was confirmed by the DNA injection method.
Fc receptors (FcR) are a group of cellular surface molecules
that specifically recognize and bind homologous immunoglob-
ulin via the Fc part and which mediate various biological
functions. For each immunoglobulin heavy chain, there are
corresponding FcR expressed on specific cells of all the major
hematopoietic lineages. FcR for immunoglobulin G (IgG)
form a heterogeneous group and link specific humoral and
cellular immune responses and thus confer antigen specificity
to phagocytic effector cells that lack receptors specific for
antigen (51). The functions triggered by FcR include phago-
cytosis, endocytosis, antibody-dependent cellular cytotoxicity,
release of inflammatory mediators, and modulation of antigen
presentation. Three types of murine and human FcR can be
distinguished. All three receptors belong to the immunoglob-
ulin supergene family, are associated with homo- and het-
erodimers, and also exist as soluble receptors (52).
FcR are also expressed by some bacteria and have been
typed according to their functional reactivities with different
species and subclasses of IgG (6). Remarkably, induction of
FcR is also a property of certain coronaviruses (38) and of
herpesviruses, including herpes simplex virus type 1 (HSV-1)
and HSV-2 (1, 3, 54), varicella-zoster virus (VZV) (37),
cytomegalovirus (CMV) (21, 27, 40, 55), and Epstein-Barr
virus (57). Baucke and Spear (3) identified Fc-binding glyco-
protein gE of HSV-1. In order to achieve full FcR activity, gE
forms a complex with a second glycoprotein, gI (4, 23-25). The
FcR genes of the herpesviruses are not members of the
immunoglobulin supergene family.
The biological role of FcR expressed by herpesviruses is
unclear. The present concept, which is supported by in vitro
data, is that the HSV-1 FcR is active in bipolar bridging of
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specific IgG (18), which reduces the efficacy of virus neutral-
ization (12) and antibody-dependent cellular cytotoxicity (15).
Induction of an FcR by a herpesvirus may also have adverse
effects, since FcR induction by CMV has been reported to
confer human immunodeficiency virus susceptibility to cells
(34).
We recently observed that in B-cell-deficient mice, the
primary infection by murine CMV (MCMV) takes the same
course in the presence and absence of antibody (26). One
explanation could be that functions specified by the virus, for
instance, induction of FcR, could modulate the activity of
antibodies. In order to test the potential immunological role of
FcR, we therefore set out to identify genes coding for a
potential FcR activity of MCMV. This should enable us to
construct and test CMV mutants that harbor or lack this
function. In this report, we describe the identification and
genomic location of a gene coding for FcR, determined by a
method involving injection of viral genomic DNA fragments
and monitoring of the expression phenotype. The gene was
sequenced and the protein was expressed by vaccinia virus.
MATERIALS AND METHODS
Cells, virus, and infection conditions. BALB.SV, a immor-
talized cell line of BALB/c murine embryonal fibroblasts
(MEF) (11), was grown in Dulbecco's modified Eagle medium
supplemented with 10% (vol/vol) fetal calf serum. MCMV
(strain Smith, ATCC VR-194) was propagated on MEF as
described previously (44). The cells were infected by the
technique of centrifugal enhancement of infectivity.
For selective expression of immediate-early proteins, the
cells were infected in the presence of cycloheximide (50
,ug/ml), which was replaced with actinomycin D (5 ,ug/ml) after
3 h of incubation (10). For selective expression of early
proteins, the cells were infected in the presence of phospho-
noacetic acid (250 mg/ml), an inhibitor of DNA synthesis.
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Preparation of viral DNA. The MCMV DNA was prepared
from the infected cells and purified by CsCl gradient centrif-
ugation as described previously (16).
Microinjection. The cells were seeded on Cell locates (Ep-
pendorf, Hamburg, Germany), and individual cells were in-jected with 50 to 100 ng of genomic or plasmid DNA per RI.
The automatic injection system from Eppendorf was used by
following the instructions of the manufacturer. Cells were
injected into the nucleus for 0.5 s at a constant pressure of 80
hPa. Under these conditions, approximately 0.05 pl of the
sample was injected, corresponding to about 200 copies of
plasmid DNA. Per Cell locate, about 150 cells were injected.
After injection, the cells were incubated for a further 24 h at
37°C and 5% CO2. The microinjected cells were fixed for 20
min in 3% (wt/vol) paraformaldehyde, and free groups were
quenched for 10 min in 50 mM NH4Cl. After permeabilization
with 0.1% Triton X-100 for 5 min and a washing in phosphate-
buffered saline, the cells were incubated with murine mono-
clonal IgG for 30 min at room temperature (35). As a
secondary antibody, fluorescein isothiocyanate-conjugated
goat anti-mouse IgG (Dianova, Hamburg, Germany) was used.
Metabolic labeling and protein analysis. Monolayers of cells
grown in 6-cm-diameter petri dishes were infected with
MCMV (multiplicity of infection of 20) or with recombinant
vaccinia viruses (multiplicity of infection of 2). The cells were
pulse-labeled with 250 ,uCi of [35S]methionine (Amersham,
Braunschweig, Germany) per ml in methionine-free Dulbec-
co's modified Eagle medium supplemented with 5% dialyzed
fetal calf serum and were chased in medium containing
unlabeled methionine. Labeled cells were lysed on ice in a
buffer containing 10 mM Tris-HCl (pH 7.4), 100 mM NaCl, 1%
Nonidet P-40, 1 mM EDTA, and 1 mM phenylmethylsulfonyl
fluoride. Cytoplasmic extracts were incubated with murine IgG
for 1 h at 4°C, and immune complexes were precipitated with
protein A-coupled Sepharose (Pharmacia, Uppsala, Sweden).
Bound complexes were eluted by heating at 96°C for 5 min in
a reducing sodium dodecyl sulfate-polyacrylamide gel electro-
phoresis (SDS-PAGE) sample buffer and analyzed by 8%
PAGE. In some experiments, Sepharose-coupled immuno-
globulin fragments and different immunoglobulin allotypes
were used. The coupling of cyanogen bromide-activated
Sepharose (Pharmacia) was done according to the instructions
of the manufacturer. Affinity-purified mouse IgG, mouse IgG
Fc fragments, and mouse IgG F(ab)2 fragments were obtained
from Dianova. N-Glycosidase F (PGNase F; Boehringer,
Mannheim, Germany) digestion was performed as described
previously (2). The precipitated proteins were denatured and
digested with PGNase F (1 U/ml) overnight.
DNA sequence analysis. The nucleic acid sequence was
determined by a modified version of the dideoxy sequencing
method (50). Both strands were sequenced with subclones and
specific primers. The Genetics Computer Group software
package, version 7.2, was used for the analysis of the nucleic
acid sequences and for the deduction of the amino acid
sequence.
RNA analysis. The cells were infected with MCMV at a
multiplicity of infection of 10. Total cellular RNA was isolated
at different times postinfection (p.i.) according to the method
of Chirgwin et al. (8). Denaturated RNA samples were size
fractionated by agarose gel electrophoresis and blotted onto a
nylon membrane (GeneScreen; NEN). Filters were prehybrid-
ized for 3 h at 68°C in 5x SSC (lx SSC is 0.15 M NaCl plus
0.015 M sodium citrate)-5 x Denhardt's solution (lx Den-
hardt's solution is 0.02% [each] bovine serum albumin [BSA],
polyvinylpyrrolidone, and Ficoll 400)-1% SDS-10% dextran
sulfate-250 ,ug of salmon sperm DNA per ml. Hybridization
was carried out overnight, under the same conditions, with
radioactively labeled probes (46). A probe identical to the
coding strand was generated on the template of the BamHI-
EcoRI fragment (map units 0.837 to 0.843) with primer
5'-CGCATAAGGTAGGACCAC-3', and a probe identical to
the opposite strand was generated on the template of the
BamHI-BglII fragment (map units 0.848 to 0.841) with primer
5'-AGACAGACCATGCCATCG-3'. Full-length cDNA from
the human fibroblast cytoplasmic ,-actin gene (22), labeled
with [a-32P]dCTP by using a randomly primed DNA labeling
system (Boehringer), served as a probe for a cellular gene.
Primer extension. The 5' end of the mRNA was determined
by primer extension. RNA (20 ,ug) was mixed with the primer
end labeled with 32p (5'-GGTAATTGATGCGCCGTCACG
GCCG-3') in a hybridization buffer (2 M NaCl, 50 mM PIPES
[piperazine-N,N'-bis(2-ethanesulfonic acid)] [pH 6.8], 0.05%
SDS), incubated for 5 min at 65°C, and then hybridized at 37°C
for 5 h. The hybridized RNA was purified by ethanol precipi-
tation and subjected to reverse transcription with avian myelo-
blastosis virus reverse transcriptase (Boehringer). The same
primer was used for the sequencing reaction. The sequencing
products and the cDNA were run on a 6% polyacrylamide gel,
and the gel was subjected to autoradiography.
Determination of the 3' end of the mRNA. The 3' end of the
MCMV FcR mRNA was determined according to the method
of Frohman et al. (20). The cDNA was synthesized by reverse
transcription with oligonucleotide (dT)17-Rl-RO (5'-AAGGA
TCCGTCGACATCGATAATACGACTCACTATAGGGAT
'1'1'1'11'1'1'1'1'1'1 '-3'), and the transcribed product was
then subjected to PCR amplification with oligonucleotides RO
(5'-AAGGATCCGTCGACATC-3') and B23-14.3-HindIII (5'-
CCGAAGC1'CTCCATCTCGATCAACGG-3'). The prim-
ers contained the restriction sites, which allowed the cloning
and sequencing of the amplified product.
Production of recombinant vaccinia viruses. Recombinant
vaccinia virus expressing the complete MCMV FcR open
reading frame (ORF) was generated as described previously
(32). Briefly, the 2,373-bp BamHI-BamHI fragment was cloned
into the vaccinia virus expression vector p7.5K, which allows
the expression of foreign proteins under the control of the
7.5-kDa early-late promoter. The virus recombinants were
produced with the DNA of vaccinia virus strain Copenhagen.
Recombinants expressing their respective MCMV FcR ORFs
were selected by infecting HU TK- 143 cells.
Nucleotide sequence accession number. The EMBL Data
Library accession number for the nucleotide sequence re-
ported in this article is X77798.
RESULTS
Identification of an MCMV early glycoprotein with IgG
binding properties. A cytoplasmic FcR activity expressed
following infection with human CMV has been reported by
Furukawa et al. (21). The expression of MCMV-induced
immunoglobulin binding activity in the infected cells was tested
accordingly. By indirect immunofluorescence, a strong cyto-
plasmic staining was observed with purified murine IgG but not
with murine IgM, indicating that MCMV encodes a function
similar to that encoded by human CMV (Fig. 1). No signal
occurred when only the labeled antiserum was used. The
fluorescence signal became detectable 5 to 6 h after infection
and reached plateau levels at about 10 h p.i. Infection of cells
in the presence of phosphonoacetic acid resulted in the same
phenotype except when immediate-early genes were expressed
because of the subsequent use of cycloheximide and actinomy-
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FIG. 1. Immunoglobulin binding activity induced by MCMV infection.
mouse IgG and subjected to indirect immunofluorescence.
Noninfected cells (a) and MCMV-infected cells (b) were stained with
cin D, indicating that induction of IgG binding is an early-
phase function (data not shown).
To identify proteins with immunoglobulin binding proper-
ties, the cells were pulse-labeled with [35S]methionine at 12 h
after infection and chased for 10, 20, and 30 min. Precipitation
with purified mouse IgG showed proteins with apparent mo-
lecular masses of 86 and 88 kDa. Some of this material was
processed to a protein of 105 kDa after 20 min of chase (Fig.
2a). Precipitation and subsequent digestion with endoglycosi-
dase F increased the electrophoretic mobilities of the 86- and
88-kDa species and the 105-kDa species to a band of 65 kDa
(Fig. 2b), indicating that the immunoglobulin-binding protein
is an early glycoprotein.
To test whether the capacity to bind immunoglobulins is
restricted to the Fc portion of the immunoglobulin molecule,
Sepharose particles were coated with purified Fc fragments,
purified F(ab)2 fragments, and complete IgG molecules. Af-
finity precipitation showed that gp86/88 is precipitated by IgG
Fc fragments but not by IgG F(ab)2 fragments (Fig. 2c).
Therefore, binding of gp86/88 and gplO5 is specific for the Fc
region of the IgG molecule, leading to the conclusion that
MCMV induces a receptor for the Fc fragment of IgG.
Identification of the FcR gene by microinjection of MCMV
DNA fragments. In order to localize the FcR gene within the
MCMV genome, we used a DNA microinjection method and
monitored the intracellular expression of an IgG binding
activity by indirect immunofluorescence. The general strategy
of the microinjection approach is outlined in Fig. 3. Twenty-
four hours after injection of complete undigested MCMV
DNA (Fig. 3a), a strong expression of FcR in the cytoplasm
can be seen (Fig. 3e). Perinuclear localization of large cyto-
plasmic vacuolar structures suggests the accumulation of FcR
protein in a distinct cytoplasmic compartment. The detection
of this pattern of fluorescence was used in further experiments
to locate the genomic position of the gene.
To this end, the MCMV DNA was first cleaved with various
restriction enzymes and the DNA fragments were inject-
ed (Fig. 3b). This type of analysis was considered to indicate
which restriction enzyme would cleave either the gene of the
a
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FIG. 2. Precipitation of glycoproteins with specificity for Fc portion
of mouse IgG from MCMV-infected cells. (a) Cells were pulse-labeled for
10 min with [35S]methionine at 12 h p.i. and chased for the indicated
period of time. Mock-infected cells were chased for 30 min. The precip-
itation from cytoplasmic extracts was done with purified mouse IgG and
protein A-Sepharose. (b) A sample precipitated with IgG as for panel a
was split into two fractions, and the smaller fraction (+), containing about
25% of the material, was digested by endoglycosidase F. (c) The MCMV-
infected cells were pulse-labeled for 1 h, and the lysates were precip-
itated with Sepharose-coupled IgG, IgG F(ab)2, IgG Fc, or BSA.
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FIG. 3. Strategy for the identification of the MCMV FcR gene. Undigested MCMV DNA (a), restriction enzyme-digested DNA (b), eluted
DNA fragments (c), and cloned restriction fragments (d) were injected into the nuclei of the cells. (e) The expression of proteins binding a mouse
monoclonal antibody of the IgG2a subtype was determined by immunofluorescence. (f) Injected cells were localized with Cell locates.
presumptive FcR or a gene required to induce the expres-
sion of the FcR. The regulatory function of immediate-early
genes is required for expression of the early genes (36).
Therefore, we assumed that the coinjection of the plasmid
pIE111, containing the iel and the ie3 genes (36), was neces-
sary for the expression of the FcR gene in further experiments.
This assumption was later proved to be correct (data not
shown).
Several restriction enzymes were tested by monitoring cells
by cytoplasmic staining after DNA injection. Whereas, for
example, no positive signal resulted after cleavage of MCMV
DNA with EcoRI, nearly 30 to 40% of injected cells were
positive after digestion with ClaI. The ClaI digestion resulted
in at least 29 MCMV DNA restriction fragments which were
isolated and coinjected with the plasmid pIE111. Injection of
isolated ClaI restriction fragments showed that the second-
largest (B) fragment of about 12 kbp must contain a gene
which either encodes or induces the FcR protein (Fig. 3c). This
fragment was cloned into the pACYC177 vector, and subfrag-
ments of the cloned fragment were retested. Injection of
various restriction subfragments led to the conclusion that the
minimal fragment which still induced the expression of the
FcR function is a 2.4-kbp fragment produced by digestion with
BamHI and containing the expected EcoRI site (Fig. 3c). This
fragment was subcloned into the pEMBL18 vector for nucle-
otide sequencing (Fig. 3d).
Nucleotide and amino acid sequences of the gene encoding
FcR. The 2.4-kbp BamHI subfragment of the ClaI B fragment
was sequenced with specific primers (Fig. 4). The sequence
analysis revealed only one ORF (1,707 nucleotides [nt]) with
the potential to encode a protein of 569 amino acids and a
calculated molecular mass of 64 kDa. This prediction was in
good agreement with the result obtained after precipitation of
the deglycosylated protein. The first ATG was found 87 nt
downstream from the TATA box in a favorable context for
initiation of translation (29). The polyadenylation consensus
sequence was located 56 nt downstream from the stop codon.
Computer-aided analysis with the Genetics Computer Group
sequence analysis software package, version 7.2, showed no
obvious nucleotide sequence homology to any known sequence
or to sequences of genes from members of the herpesvirus
family. The gene was designated fcrl.
The amino acid sequence of the MCMV FcR was deduced
from the nucleotide sequence of the fcrl ORF. The hydropho-
bic and hydrophilic domains of the protein were analyzed. A
hydrophobic region at the N terminus represents a putative
signal peptide sequence of 17 residues, according to the
algorithms of von Heijne (53). A second hydrophobic region of
18 amino acids probably representing the transmembrane
region, which is followed by a 17-amino-acid cytoplasmic tail,
was identified at the C terminus (positions 535 to 552). The
- C
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gcgcgactcaggcgggatcgacgagcaacaacatggaaaccggctccgatcgctagtcca
gcggcgctgtgtcagccgctcgcgggggggcgcgcagcaaccatcagtctataaaagccg
tgccgcatcacagaaactcTGTCACAGAGCGCGAGCTCAAGTCGCCATCATCTCTCGGTC
GGCAGAGCCGAGGCGATGGCGCCTTCGACGCTGATCGCACTCTGCCTCCTCGCGGCCGTG
l A P S T L I A L C L L A A V
ACGGCGCATCAATTACCTGCGTGCCAGTGGCGCTTGCCCACAGAGACCTCCGTCCCGTTC
T A H Q L P A C Q W R L P T E T S V P F
AATATCTCCTGCGACCTGGTGAACGGCTCCACGGTCAAGGTCTGGCGAGACCTCTGCGGC
N I S C D L V N G S T V K V W R D L C G
GAAGGCAATGCTACCGAGGGATGGATCGGGATGGCCCGGCGCGGAGACAAATTACATTTC
E G N A T E G W I G M A R R G K L H F
TCCGCCAGGTGGAACTACTCGACCGCCGACATCGGGGTCTACTACGTCAACGTGACCGAG
S A R W N Y S T A D I G V Y Y V N V T E
CGTAACCTGACGACTCCCCTGACGCAACTGATCACCCCACCGATGACGATCTGGGGCATG
R N L T T P L T Q L I T P P M T I W G M
AGGCAGGGCGGCAGAAGCAGAGACTTTGTCCTCTGCACCGTGACGGGCATCTTCTCGAAG
R Q G G R S R D F V L C T V T G I F S K
GGTGAATTCACACTCGAGGCGAACGGCGCGACGGTTCTCTCTGTCAACTTCACAAAACCC
G E F T L E A N G A T V L S V N F T K P
GGACGATATGCAGTGAAAAAAGCGCGCGTCTCTCTAGACCTCTCACATCGCAACGGTACC
G R Y A V K K A R V S L D L S H R N G T
ATGCGATTTCTCGTCTCGATCAGAGGGGGGCCCATGACGCACGTGAAATATCAGTGCATC
M R F L V S I R G G P M T H V K Y Q C I
ATGACTCCTCTCTCGTGCGTTCCTTTTGCGDTCAGCAAGCCTCTGATGTTGGAATACAGA
M T P L S C V P F A V S K P L M L E Y R
CAGACCATGCCATCGGGAGTGAAAAGGTACACCAAGGACTCCACCGGGACTGAAGTCGCC
Q T M P S G V K R Y T K D S T G T E V A
AACAGAGTCTGCTGTAAGCTCGATGATTACCATAACTGGGATTTCGCCAAGCGCGTCACC
N R V C C K L D D Y H N W D F A K R V T
GTGACCAGAACGACCGTCCAGTGCGCAGAACCCCAGTTCTTGTTTGCCTTCGACATCCCG
V T R T T V Q C A E P Q F L F A F D I P
CCGTACATGTTCTACATAGCCGCGGTGGAAAAGCCGCTGGAATCGGTCTTGATGCTGTAC
P Y M F Y I A A V E K P L E S V L M L Y
GACGTCGACACATGGAACTACGCTTTCACCTCCAGTGGCGTATGCATACAAACATCTAAA
D V D T W N Y A F T S S G V C I Q T S K
K T G V G L P P G E Y Q C I F E R E S G
TCGTTATACGGCCGTCCGCTGATGGTACACGGCAGCATAACGATCGAGGCGAAGACGACA
S L Y G R P L M V H G S I T I E A K T T
CACGACTTCGTGAGTAGAGTCGAGATCCAAATAACGTGTACCTTCGACGCGGTGTCCGAC
H D F V S R V E I Q I T C T F D A V S D
GGCGCGTTCACGCTGGAGCGCGTGGAAGACGGACAGCCGGTGTATCAGAGCCGTGTCGGC
G A F T L E R V E D G Q P V Y Q S R V G
ACTAACGAGTCCTTCGTCTCCGACGACTCCATCTCGATCAACGGCTCGCGGCTGTCCGAG
T N E S F V S D D S I S I N G S R L S E
GGCAAGATCTCGGTGTCCGTGTACCTGAGAGAAGACGATGGCGTGATCGGCCGGTTTAGG
G K I S V S V Y L R E D D G V I G R F R
TGCCGCGTCCGCTCGGGATGCTTGAATCTGGTATCCCGAGCGATCACCGTGACGAAGCCC
C R V R S G C L N L V S R A I T V T K P
ACCAGGATGGAATACGCCCTCGTGACAGAGGAGCCCGTCACGTCCCCTCAGACCACCACC
T R M E Y A L V T E N P V T S P Q T T T
ACTACTACTACGACGACCACAACACCATCACCCCCCTCACCCGCCAAGAAACTAGAAGAG
T T T T T T T T P S P P S P A K K L E E
ATCAGAATAAAGGTCGACGGAACCGACGACGATGACTTTCTGTTGGAGACGCAAGAACCG
I R I K V D G T D D D D F L L E T Q E P
CTCAAAAGCTACCCCTACTATCCTCTATTCGCTCGCGTCAGCGCGGAAGGCCGTCTGGCG
L K S Y P Y Y P L F A R V S A E G R L A
GCCGTCGCTTGTTTCTTCCTAGCCGCGATCCTCGTGTTGGTCCACATCTCGTTCTGDATC
A V A C F F L A A I L V L V H I F W I
TCGTCGCCGCCGTGTAACCTDCCGGGTTGCGTACGTCACACGTAACTCAAGTCATCGACT
S S P P C N L P G C V R H T
ACTAACACTTACTAATGACTGACCCCCAGCATATATAAATAAAAGCTCTCAAACTAGaca
cggttccttcattactctgttattttcggtctccgacgggtcacggCtCtCttgCctCtc
tctccatgtggcgatactggtatcggggcgccatcgcggcgatagtcgcggccgtcacca
cgacggcactgatagccccgggggggtgggatcc
FIG. 4. Nucleotide and predicted amino acid sequences of the
MCMV FcR gene. The nucleotide sequence of the 2.4-kbp BamHI-
BamHI fragment is shown. The predicted mRNA is in capital letters.
The TATA box and polyadenylation consensus sequence are in
boldface. The predicted amino acid sequence is displayed in the
one-letter code. The putative signal sequence and transmembrane
region are in boldface. The RGD motif and PEST region are shown by
underlined boldface letters. Potential N-linked glycosylation sites are
underlined.
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FIG. 5. Transcriptional kinetics of FcR gene expression. (a) Total
cellular RNA isolated at different times after infection was hybridized
with a strand-specific probe. (b) As a control, filters were rehybridized
with a probe specific for a cellular gene, the 1-actin gene.
putative transmembrane glycoprotein has 10 potential N-
linked glycosylation sites.
At positions 68 to 71, the sequence contains the tripeptide
Arg-Gly-Asp (RGD). This sequence represents a ligand rec-
ognition motif for several integrins (39, 56). Proximal to the
transmembrane region, a region rich in proline (P), glutamic
acid (E), serine (S), and threonine (T), a PEST region (43, 45),
was identified (positions 458 to 490). This type of region is
characteristic for eucaryotic proteins with intracellular half-
lives of less than 2 h (44, 46).
Characteristics of thefcrl gene. To determine the expres-
sion kinetics of the fcrl mRNA, total cellular RNA was
isolated at different times after infection and Northern (RNA)
hybridization was performed. Hybridization with the 32P-
labeled, single-strand-specific probes containing the fcrl ORF
and generated by runoff synthesis (49) revealed the appearance
of four transcripts that were 1.9, 3.3, 4.4, and 6.0 kb (Fig. 5). All
four transcripts originate from the same strand, since no
hybridization was detected with a probe specific for the
opposite strand (data not shown). On the basis of the size of
fcrl mRNA, which can be predicted from the nucleotide
sequence, and on the basis of the gene injection experiments,
the 1.9-kb transcript must represent the mRNA for the fcrl
gene.
Transcription was found to start as early as 2 h after
infection and to continue throughout the MCMV replication
cycle (Fig. 5a). Maximal transcriptional activity was observed
between 8 and 16 h p.i. The same filters were rehybridized with
a probe specific for a cellular gene, the ,B-actin gene, to assess
the amount of RNA loaded on the gel (Fig. Sb).
The 5' end of the fcrl mRNA was determined by primer
extension. A primer was hybridized 150 nt upstream of the
putative start site. The resulting cDNA (Fig. 6a) is seen
adjacent to the sequencing products with the same primer. The
first nucleotide of the mRNA is the T at position 379, 31 nt
downstream of the TATA box and 92 nt upstream of the ATG
(Fig. 4).
The 3' end of the fcrl transcript was determined by reverse
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FIG. 6. Characterization of the FcR mRNA. (a) The 5' end was
determined by primer extension. The leading nucleotide is marked
with an asterisk. (b and c) The 3' end was determined by PCR
amplification after reverse transcription. The nucleotide sequences of
both strands of the cloned PCR product are shown. The leading
nucleotides are marked with asterisks.
transcription of the mRNA and amplification of the cDNA
(20) (Fig. 6b and c). In brief, the primer (dT)17-R1-R0 was
annealed to RNA and reverse transcription was performed.
Amplification of the fcrl cDNA was achieved with fcrl-specific
primer 5'-AGACAGACCATGCCATCG-3' and primer RO
(Fig. 6b and c). After sequencing of this amplified fragment,
the 3' end of thefcrl mRNA could be located at position 2216,
18 nt downstream of the polyadenylation signal. This predicts
a calculated size of 1,838 nt for the fcrl mRNA, which is in
good agreement with the size of the mRNA identified by
Northern hybridization.
Expression of the MCMV FcR by a recombinant vaccinia
virus. A recombinant vaccinia virus expressing the MCMV
FcR ORF was constructed in order to test whether the cloned
gene indeed encodes a protein which binds the Fc fragment of
IgG. The FcR gene product synthesized in vaccinia virus
FcR-infected cells was characterized by immunoprecipitation
of [35S]methionine-labeled proteins with purified IgG and with
polyclonal anti-MCMV serum. Proteins with apparent molec-
ular masses of 86 and 88 kDa were equally expressed in cells
infected with the recombinant vaccinia virus. They were pre-
cipitated by both IgG and MCMV-specific antiserum (Fig. 7).
This result proved that the fcrl gene identified by microinjec-
tion is identical to the gene coding for the protein which is
precipitated by IgG from MCMV-infected cell lysates.
Genomic localization of the fcrl gene. The fcrl gene was
located by Southern analysis in the Hindlll J fragment of the
MCMV genome (data not shown) between map units 0.838
and 0.846 (Fig. 8). The gene is located upstream of the sggl
gene (33) and a PL3 transcript (7) reported by Cardin et al.
Four transcripts of significantly different sizes were identified
after hybridization with a gene-specific probe (Fig. 5), indicat-
ing a complex transcription pattern at this genomic region. All
four transcripts coterminate, suggesting the existence of adja-
cent ORFs upstream of the fcrl gene within the HindIlI I
cleavage fragment.
DISCUSSION
This report describes the localization, sequencing, and vec-
tor-mediated expression of a gene of MCMV that codes for a
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FIG. 7. Expression of the FcR gene by vaccinia virus vector. The
cells were infected with wild-type vaccinia virus strain Copenhagen
(Vac wt) (lane 1), vaccinia virus gB (Vac gB) (42) (lane 2), and
recombinant vaccinia virus expressing the fcrl ORF (Vac fcrl) (lanes
3 and 4). [35S]methionine-labeled cell lysates (60-min pulse) were
precipitated with mouse anti-MCMV serum (lanes 1 to 3) or with
mouse IgG (lane 4).
protein with IgG Fc binding properties. In absence of a specific
antiserum, the transient expression of this Fc binding pheno-
type was used to identify the gene. The microinjection tech-
nique proved to be convenient and straightforward, because
the use of a small amount of genomic viral DNA already
digested by restriction enzymes allowed a rather precise loca-
tion of the gene prior to the cloning procedure. No false-
positive results were obtained, probably because the phenotype
of injected cells could be directly compared with that of
adjacent noninjected cells. The products of the gene termed
fcrl are early glycoproteins which represent, as judged by
sequence, size, and function, bona fide homologs of the gE
proteins of HSV-1 and VZV.
No homologous gene of human CMV is known. The strong
cytoplasmic binding of human IgG induced by human CMV
was reported long ago (21, 27). At the cell surface, the
reactivity is stronger with aggregated IgG than with monomeric
IgG (19). Generally, the level of surface FcR expression varies
among herpesviruses, which led to controversial data with
regard to surface expression of VZV FcR (for a review, see
reference 30). The surface expression of human CMV FcR is
thought to facilitate the entrance of viruses into CMV-infected
cells (34). We also observed that for MCMV-infected cells, the
intracellular binding of monomeric IgG is much stronger and
more consistent than the interaction at the cell membrane
(data not shown). In the absence of a specific antiserum for the
protein, the strong cytoplasmic expression of the Fc binding
property was preferred for identifying the coding region in the
genome.
Transcriptional kinetics identified the coding gene, which
was termedfcrl, as an early gene that is expressed from 2 h p.i.
on throughout the replication cycle. The determined length of
1,838 nt for the fcrl mRNA is in good agreement with the
length of 1.9 kb for the polyadenylated mRNA found early
after infection; the polyadenylated mRNA is the shortest
member of a family of four early transcripts. This RNA family
a)
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FIG. 8. Genomic localization of the MCMV fcrl gene. Shown is the HindIII cleavage map of the MCMV genome (top) and the known
transcripts encoded by the HindIII K, L, and J fragments (bottom). Localization of the fcrl ORF is indicated by an open box with an arrow. The
other early (p) transcripts are represented by dashed lines and were not further characterized.
is transcribed from the same strand in the same direction, and
all four transcripts probably coterminate with the fcrl mRNA.
This conclusion was based on the finding that after cDNA
synthesis and PCR amplification, only a single fragment that
defined the 3' end of the fcrl mRNA was obtained. Although
this PCR method amplifies fragments in a certain size range, it
is unlikely that a member of this mRNA family terminates
further downstream, because another 1.3-kb early RNA has
been mapped to the adjacent region (7). Multiple and longer
transcripts from the same strand also occur in the regions of
the gB and polymerase genes ofMCMV and human CMV (17,
28, 31, 42, 47) as well as in the region encoding the gH of
MCMV (41).
The fcrl gene predicts an ORF with the potential to encode
a protein of 569 amino acids. This protein is a type I glyco-
protein with an N-terminal secretory signal sequence of 17
residues and a transmembranal region extending from posi-
tions 535 to 552 followed by a cytoplasmic tail of 17 amino
acids. The size of an early glycoprotein which was detected in
infected cells and which migrates at a relative mobility of 64
kDa after deglycosylation is also in good agreement with the
predicted molecular mass of the fcrl gene product, and proof
for identity was provided by vaccinia virus expression of fcrl.
Because of the lack of a specific antibody, the characterization
of the fcrl gene product has been limited to precipitation by
IgG. Work to define the conditions of IgG binding by the fcrl
product and its biochemical properties in more detail is in
progress. Studies of the biochemical properties of human
CMV proteins with Fc binding functions revealed four proteins
of 38, 50, 65, and 130 kDa (5). The latter two proteins were
also found in virions. Stannard and Hardie (48) detected
Fc-binding polypeptides of 33 and 69 kDa and also associated
Fc binding activity with the tegument of human CMV. Our
studies of the proteins expressed after infection have been
restricted to short-term pulse-chase experiments. Analysis of
proteins expressed by vaccinia virus also showed gp86/88 and
gplO5. This does not exclude further modifications, since we
have observed that MCMV glycoproteins can be processed
differently after expression by MCMV and by vaccinia virus
(42).
If the FcR of CMV is homologous with the receptor of
alphaherpesviruses, which is a heterodimer composed of the
glycoproteins gE and gI (25), then the protein we describe is
probably the homolog of gE. This conclusion is based on the
facts that only the gE protein of HSV-1 has intrinsic Fc binding
activity and that its interaction with gI endows gE with the
ability to interact with both IgG monomers and aggregates. At
550 residues for HSV-1 gE and 623 for VZV gE, all three
proteins fall into a similar size class. The two genes for HSV-1
and VZV gE have an identity of 19% and a similarity of 34%.
A comparison of the amino acid sequence of HSV-1 gE with
the sequence of fcrl reveals an identity of 14.3% and a
similarity of 38.6%, and a comparison of the VZV gE sequence
with the fcrl sequence reveals an identity and a similarity of
13.9 and 41.1%, respectively (data not shown). In addition, the
N-terminal region of fcrl contains the RGD tripeptide cell
adhesion motif shared by many cell adhesion molecules (13)
and which is absent from the FcyR of HSV-1 and VZV.
Finally, the sequence contains a PEST motif which is typical
for proteins with a short half-life (43, 45). The functional
relevance of these sequence motifs and of the Fc binding
property is unknown at present. At least three possibilities
exist. The first is that the FcR indeed has a function that allows
the virus to evade immune control, a function similar to the
effect of the so-far-unknown early gene products affecting the
export of peptide-loaded major histocompatibility complex
class I molecules (9). Second, the FcR property could be
irrelevant for the in vivo function of the gene product and
could perhaps indicate a propensity to interact with certain
glycoproteins. The finding that the surface expression of the
VZV FcR is rather weak and that in CMV the protein is
mainly in the cytoplasm and is associated with the tegument of
the virion may indicate such a possibility. The third possibility
is that the protein has more than one function. Recent work by
Dubin et al. (14) suggesting a homology of a domain of the
HSV-1 gE that is involved in Fc binding with mammalian FcR
sequences seems to support the immunological role.
Our interest in the potential immunoevasive role of herpes-
virus FcR was raised when we found that antibodies are not
essential to combat acute MCMV infection and to establish
viral latency (26). This could indicate either that the antibody-
binding FcR function is irrelevant during MCMV infection or
that this property indeed makes an important contribution and
is directly responsible for the only apparent irrelevance of
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antibodies during acute infection. Under the assumption that
the homologous genes should be nonessential for the virus,
we have started to construct MCMV mutants by insertional
mutagenesis. Although further testing is required, it is already
clear that a mutant harboring a truncated form of the fcrl
gene still replicates in tissue culture (49a). Thus, the phenotype
of a CMV infection in the presence and absence of FcR
functions will soon become testable in a natural virus host
model.
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